CAPRICOR THERAPEUTICS, INC. (CAPR)
About CAPRICOR THERAPEUTICS, INC.
Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with high unmet medical needs. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $0
- Net income
- -$105.0M
- Total assets
- $355.9M
- Market cap
- $1.1B
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $1.1B
- Shares outstanding
- 187.0M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jun 20, 2002
Capricor Therapeutics, Inc. (CAPR) Stock Price
- Reported a net loss of $105.0M in FY2025.
- Trading 83% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review CAPRICOR THERAPEUTICS, INC..
Write a review
News about CAPRICOR THERAPEUTICS, INC.
News & sentiment via Polygon.io
Capricor Therapeutics, Inc.: frequently asked questions
Is Capricor Therapeutics, Inc. an American company?
Capricor Therapeutics, Inc. is a US-based company headquartered in San Diego, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Capricor Therapeutics, Inc. headquartered?
Capricor Therapeutics, Inc. is headquartered in San Diego, California, United States.
Is Capricor Therapeutics, Inc. publicly traded?
Yes — Capricor Therapeutics, Inc. is a publicly traded company. Its stock trades under the ticker symbol CAPR on the NASDAQ.
What does Capricor Therapeutics, Inc. do?
Capricor Therapeutics, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
